COM:LESVI
Neuraxpharm Pharmaceuticals
- Privately Held
Company Information
| msh id | COM:LESVI |
| symbol | - |
| name | Neuraxpharm Pharmaceuticals |
| homepage url | https://www.lesvi.com/ |
| country | ES |
| sector | Healthcare & Health Services |
| industry | Pharmaceuticals |
| market | PRIVATE |
| employee count | - |
| crunchbase url | - |
| linkedin url | - |
| founders | - |
Market Metrics
| market cap | - |
| enterprise value | - |
| stage | - |
| raised capital | - |
| valuation | - |
Web & Growth Metrics
| monthly webtraffic | - |
| monthly webtraffic growth | - |
| growth score 14 | - |
| growth score 28 | - |
| growth score 90 | - |
| growth score 365 | - |
LTM & NTM Metrics
| revenue ltm | - |
| gross profit ltm | - |
| ebitda ltm | - |
| net income ltm | - |
| revenue ntm | - |
| gross profit ntm | - |
| ebitda ntm | - |
| net income ntm | - |
Growth & Performance Metrics
| growth cost and expenses | - |
| growth cost of revenue | - |
| growth depreciation and amortization | - |
| growth ebitda | - |
| growth ebitda ratio | - |
| growth eps | - |
| growth eps diluted | - |
| growth general and administrative expenses | - |
| growth gross profit | - |
| growth gross profit ratio | - |
Operating Metrics
| cost and expenses | - |
| cost of revenue | - |
| depreciation and amortization | - |
| ebitda | - |
| ebitda ratio | - |
| eps | - |
| eps diluted | - |
| operating expenses | - |
| operating income | - |
| operating income ratio | - |
Balance Sheet Metrics
| accounts receivables | - |
| capital expenditure | - |
| cash at beginning of period | - |
| cash at end of period | - |
| inventory | - |
| working capital ttm | - |
Financial Metrics (2022-2026)
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Revenue Metrics | |||||
| Revenue | - | - | - | - | - |
| Revenue Growth | - | - | - | - | - |
| Revenue Multiple | - | - | - | - | - |
| Profit Metrics | |||||
| Gross Profit | - | - | - | - | - |
| Gross Profit Growth | - | - | - | - | - |
| Gross Profit Multiple | - | - | - | - | - |
| EBITDA Metrics | |||||
| EBITDA | - | - | - | - | - |
| EBITDA Growth | - | - | - | - | - |
| EBITDA Multiple | - | - | - | - | - |
| Net Income Metrics | |||||
| Net Income | - | - | - | - | - |
| Net Income Growth | - | - | - | - | - |
| Net Income Multiple | - | - | - | - | - |